Harvard Bioscience (HBIO) Non-Current Debt (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Non-Current Debt of $36.2 million for Q1 2026, up 0.95% quarter-over-quarter from $35.9 million in Q4 2025.
Harvard Bioscience (HBIO) Non-Current Debt (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Non-Current Debt for 17 consecutive years, with $36.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt changed N/A year-over-year to $36.2 million; the TTM figure through Mar 2026 stood at $36.2 million (changed N/A YoY), while the FY2025 annual figure was $35.9 million, changed N/A from the prior year.
- Non-Current Debt climbed to $36.2 million in Q1 2026 per HBIO's latest filing, from $35.9 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $49.0 million in Q1 2022 and bottomed at $31.9 million in Q1 2024.
- Historically, Non-Current Debt has averaged $39.9 million across 5 years, with a median of $37.9 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Debt climbed 17.7% — and 2024, when it dropped 27.61%.
- Harvard Bioscience's Non-Current Debt stood at $43.0 million in 2022, then fell by 15.0% to $36.6 million in 2023, then climbed by 3.54% to $37.9 million in 2024, then fell by 5.25% to $35.9 million in 2025, then gained by 0.95% to $36.2 million in 2026.
- Business Quant data shows HBIO's Non-Current Debt at $36.2 million in Q1 2026, $35.9 million in Q4 2025, and $37.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 36.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.68 Mn |
| Mar 31, 2026 | 36.21 Mn |
| Dec 31, 2025 | 35.87 Mn |
| Sep 30, 2024 | 37.86 Mn |
| Jun 30, 2024 | 31.96 Mn |
| Mar 31, 2024 | 31.89 Mn |
| Dec 31, 2023 | 36.56 Mn |
| Sep 30, 2023 | 35.27 Mn |
| Jun 30, 2023 | 41.42 Mn |
| Mar 31, 2023 | 44.05 Mn |
| Dec 31, 2022 | 43.01 Mn |
| Sep 30, 2022 | 46.53 Mn |
| Jun 30, 2022 | 48.48 Mn |
| Mar 31, 2022 | 48.96 Mn |
| Dec 31, 2021 | 48.33 Mn |
| Sep 30, 2021 | 45.21 Mn |
| Jun 30, 2021 | 43.14 Mn |
| Mar 31, 2021 | 41.60 Mn |
| Dec 31, 2020 | 46.29 Mn |
| Sep 30, 2020 | 43.48 Mn |